Rupatadine Protects against Pulmonary Fibrosis by Attenuating PAF-Mediated Senescence in Rodents

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Lv, Xiao xi ^a   Wang, Xiao xing ^a   Li, Ke ^a   Wang, Zi yan ^a   Li, Zhe ^a   Lv, Qi ^a   Fu, Xiao ming ^a   Hu, Zhuo Wei ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; BLEOMYCIN; COLLAGEN; CYTOKINE; LORATADINE; PIRFENIDONE; PROTEIN P21; PROTEIN P53; RUPATADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG FUNCTION; MALE; MOUSE; NONHUMAN; PNEUMONIA; RAT; SENESCENCE;

ANIMALS; CELL AGING; CYPROHEPTADINE; LUNG; MALE; MICE; MICE, INBRED C57BL; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880300767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068631     Document Type: Article

References (51)

1. Wynn TA, (2011) Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350. doi:10.1084/jem.20110551. PubMed: 21727191.
2. Noble PW, Barkauskas CE, Jiang D, (2012) Pulmonary fibrosis: Patterns and perpetrators. J Clin Invest 122: 2756-2762. doi:10.1172/JCI60323. PubMed: 22850886.
3. du Bois RM, (2010) Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov 9: 129-140. doi:10.1038/nrd2958. PubMed: 20094055.
4. Fernandez IE, Eickelberg O, (2012) New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 380: 680-688. doi:10.1016/S0140-6736(12)61144-1. PubMed: 22901889.
5. Yang HZ, Cui B, Liu HZ, Chen ZR, Yan HM, et al. (2009) Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment. J Immunol 182: 692-702. PubMed: 19109203.
6. Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, et al. (2010) Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and th1/th2 balance. Respir Res 11: 31. doi:10.1186/1465-9921-11-31. PubMed: 20298567.
7. Mi S, Li Z, Yang HZ, Liu H, Wang JP, et al. (2011) Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and-independent mechanisms. J Immunol 187: 3003-3014. doi:10.4049/jimmunol.1004081. PubMed: 21841134.
8. Kotsianidis I, Nakou E, Bouchliou I, Tzouvelekis A, Spanoudakis E, et al. (2009) Global impairment of CD4+ CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179: 1121-1130. doi:10.1164/rccm.200812-1936OC. PubMed: 19342412.
9. de Mello LM, Bechara MI, Solé D, Rodrigues V, (2009) Th1/Th2 balance in concomitant immediate and delayed-type hypersensitivity diseases. Immunol Lett 124: 88-94. doi:10.1016/j.imlet.2009.04.011. PubMed: 19433108.
10. Sokol CL, Barton GM, Farr AG, Medzhitov R, (2008) A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 9: 310-318. doi:10.1038/ni1558. PubMed: 18300366.
11. Wang YH, Liu YJ, (2008) The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol 20: 697-702. doi:10.1016/j.coi.2008.09.004. PubMed: 18832032.
12. Summers SA, Gan PY, Dewage L, Ma FT, Ooi JD, et al. (2012) Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. Kidney Int 82: 676-685. doi:10.1038/ki.2012.211. PubMed: 22673890.
13. Kohyama T, Yamauchi Y, Takizawa H, Kamitani S, Kawasaki S, et al. (2010) Histamine stimulates human lung fibroblast migration. Mol Cell Biochem 337: 77-81. doi:10.1007/s11010-009-0287-y. PubMed: 19851834.
14. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR Jr, (2003) Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111: S18-S36. doi:10.1067/mai.2003.25. PubMed: 12532084.
15. Lang YD, Chang SF, Wang LF, Chen CM, (2010) Chymase mediates paraquat-induced collagen production in human lung fibroblasts. Toxicol Lett 193: 19-25. doi:10.1016/j.toxlet.2009.12.001. PubMed: 19969051.
16. Metz M, Maurer M, (2011) Rupatadine for the treatment of allergic rhinitis and urticaria. Expert Rev Clin Immunol 7: 15-20. doi:10.1586/eci.10.85. PubMed: 21162645.
17. Picado C, (2006) Rupatadine: Pharmacological profile and its use in the treatment of allergic disorders. Expert Opin Pharmacother 7: 1989-2001. doi:10.1517/14656566.7.14.1989. PubMed: 17020424.
18. De Lisle RC, Meldi L, Roach E, Flynn M, Sewell R, (2009) Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse. PLOS ONE 4: e4283. doi:10.1371/journal.pone.0004283. PubMed: 19172182.
19. Reddy GK, Enwemeka CS, (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29: 225-229. doi:10.1016/0009-9120(96)00003-6. PubMed: 8740508.
20. Redente EF, Higgins DM, Dwyer-Nield LD, Orme IM, Gonzalez-Juarrero M, et al. (2010) Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol 88: 159-168. doi:10.1189/jlb.0609378. PubMed: 20360403.
21. Phillips JE, Peng R, Burns L, Harris P, Garrido R, et al. (2012) Bleomycin induced lung fibrosis increases work of breathing in the mouse. Pulm Pharmacol Ther 25: 281-285. doi:10.1016/j.pupt.2011.10.001. PubMed: 22024054.
22. Lim E, Modi K, Christensen A, Meganck J, Oldfield S, et al. (2011) Monitoring tumor metastases and osteolytic lesions with bioluminescence and micro CT imaging. J Vis Exp: pp. e2775. PubMed: 21525842.
23. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, et al. (2007) The myofibroblast: One function, multiple origins. Am J Pathol 170: 1807-1816. doi:10.2353/ajpath.2007.070112. PubMed: 17525249.
24. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142. doi:10.1038/nrm1835. PubMed: 16493418.
25. Carter NJ, (2011) Pirfenidone: In idiopathic pulmonary fibrosis. Drugs 71: 1721-1732. doi:10.2165/11207710-000000000-00000. PubMed: 21902295.
26. Vasiadi M, Kalogeromitros D, Kempuraj D, Clemons A, Zhang B, et al. (2010) Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli. Int Arc Allergy Immunol 151: 38-45. doi:10.1159/000232569. PubMed: 19672095.
27. McNeil HP, Shin K, Campbell IK, Wicks IP, Adachi R, et al. (2008) The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. Arthritis Rheum 58: 2338-2346. doi:10.1002/art.23639. PubMed: 18668540.
28. Prokop S, Heppner FL, Goebel HH, Stenzel W, (2011) M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. Am J Pathol 178: 1279-1286. doi:10.1016/j.ajpath.2010.11.065. PubMed: 21356378.
29. Andrade MR, Amaral EP, Ribeiro SC, Almeida FM, Peres TV, et al. (2012) Pathogenic mycobacterium bovis strains differ in their ability to modulate the proinflammatory activation phenotype of macrophages. BMC Microbiol 12: 166. doi:10.1186/1471-2180-12-166. PubMed: 22863292.
30. Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M, (2007) TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans 035: 661-664. doi:10.1042/BST0350661. PubMed: 17635115.
31. Shivshankar P, Brampton C, Miyasato S, Kasper M, Thannickal VJ, et al. (2012) Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice. Am J Respir Cell Mol Biol 47: 28-36. doi:10.1165/rcmb.2011-0349OC. PubMed: 22362388.
32. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, et al. (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133: 1006-1018. doi:10.1016/j.cell.2008.03.038. PubMed: 18555777.
33. Rubinsztein DC, Mariño G, Kroemer G, (2011) Autophagy and aging. Cell 146: 682-695. doi:10.1016/j.cell.2011.07.030. PubMed: 21884931.
34. Lin H, Hua F, Hu ZW, (2012) Autophagic flux, supported by toll-like receptor 2 activity, defends against the carcinogenesis of hepatocellular carcinoma. 12:1859-61.
35. Coppé JP, Desprez PY, Krtolica A, Campisi J, (2010) The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol 5: 99-118. doi:10.1146/annurev-pathol-121808-102144. PubMed: 20078217.
36. Soroosh P, Doherty TA, (2009) Th9 and allergic disease. Immunology 127: 450-458. doi:10.1111/j.1365-2567.2009.03114.x. PubMed: 19604299.
37. Malmhäll C, Bossios A, Rådinger M, Sjöstrand M, Lu Y, Lundbäck B, et al. (2012) Immunophenotyping of circulating T helper cells argues for multiple functions and plasticity of T cells in vivo in humans--possible role in asthma. PLOS ONE 7: e40012. doi:10.1371/journal.pone.0040012. PubMed: 22768198.
38. Giri SN, Hyde DM, Nakashima JM, (1986) Analysis of bronchoalveolar lavage fluid from bleomycin-induced pulmonary fibrosis in hamsters. Toxicol Pathol 14: 149-157. doi:10.1177/019262338601400202. PubMed: 2429361.
39. Okamoto T, Iwata S, Ohnuma K, Dang NH, Morimoto C, (2009) Histamine H1-receptor antagonists with immunomodulating activities: Potential use for modulating T helper type1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases. Clin Exp Immunol 157: 27-34. doi:10.1111/j.1365-2249.2009.03958.x. PubMed: 19659767.
40. Giri SN, Sharma AK, Hyde DM, Wild JS, (1995) Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters. Exp Lung Res 21: 287-307. doi:10.3109/01902149509068833. PubMed: 7539741.
41. Rodier F, Campisi J, (2011) Four faces of cellular senescence. J Cell Biol 192: 547-556. doi:10.1083/jcb.201009094. PubMed: 21321098.
42. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, et al. (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667. doi:10.1016/j.cell.2008.06.049. PubMed: 18724938.
43. Tsuji T, Aoshiba K, Nagai A, (2010) Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respiration 80: 59-70. doi:10.1159/000268287. PubMed: 20016134.
44. Linge A, Weinhold K, Bläsche R, Kasper M, Barth K, (2007) Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells. Int J Biochem Cell Biol 39: 1964-1974. doi:10.1016/j.biocel.2007.05.018. PubMed: 17662641.
45. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J, (2009) Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A 106: 17031-17036. doi:10.1073/pnas.0905299106. PubMed: 19805069.
46. Levine B, Mizushima N, Virgin HW, (2011) Autophagy in immunity and inflammation. Nature 469: 323-335. doi:10.1038/nature09782. PubMed: 21248839.
47. Fujii S, Hara H, Araya J, Takasaka N, Kojima J, et al. (2012) Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease. OncoImmunology 1: 630-641. doi:10.4161/onci.20297. PubMed: 22934255.
48. Yang HZ, Wang JP, Mi S, Liu HZ, Cui B, et al. (2012) Tlr4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury. Am J Pathol 180: 275-292. doi:10.1016/j.ajpath.2011.09.019. PubMed: 22062220.
49. Liu H, Mi S, Li Z, Hua F, Hu ZW, (2013) Interleukin 17A inhibits autophagy through activation of PIK3CA to interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial cells. Autophagy 5: 730-742. PubMed: 23514933.
50. Katiyar S, Prakash S, (2009) Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis. Prim Care Respir J 18: 57-68. PubMed: 18695846.
51. Donado E, Izquierdo I, Pérez I, García O, Antonijoan RM, et al. (2010) No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: Results from a 'thorough QT/QTc study' performed according to ICH guidelines. Br J Clin Pharmacol 69: 401-410. doi:10.1111/j.1365-2125.2009.03599.x. PubMed: 20406224.